Pediatrix Medical Group IncMD
Price$25.76Intrinsic value$23.2110% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $23.21median of 6 methods · middle span $15-$49based on filings through 30 Jun 2026
Market Price $25.76Price as of 1 Oct 2026
Margin of Safety -9.9%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 0.8% (near-term consensus, capped) · years 2–5: 7.3%/yr (balance of the path).6.0% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 66.5%Yr 75.6%Yr 84.7%Yr 93.9%Yr 103.0%
7.3% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 1 window (7y) (limited history)-5.7%
Discount rate (cost of equity) 8.4%
Volatility vs market (adjusted beta)0.77

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetPediatrix Medical Group IncMDHealth Care
Valuation
P/E12.3×
P/S1.1×
P/B2.4×
EV / Revenue1.2×
EV / EBITDA7.9×
Profitability
Gross margin—
Operating margin10.9%
Net margin9.0%
FCF margin—
Returns
ROE19.8%
ROA8.2%
ROIC14.5%
Growth
Revenue growth (YoY)-3.1%
5-yr fwd EPS growth6.0%
Financial strength
Debt / Equity0.69×
Current ratio1.32×
Altman Z-Score2.4
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.